Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Access topic
No spam. Unsubscribe anytime.
Committee approves amended bill limiting new contract‑pharmacy restrictions, vests enforcement with Attorney General
Summary
House Bill 12-42 was amended to give enforcement authority to the Attorney General, grandfather existing contract‑pharmacy restrictions through June 1, and include provisions about the use of 340B savings; the subcommittee voted to move the bill to full finance 11-0.
The subcommittee voted 11-0 to advance House Bill 12-42, an amended bill the sponsor said would protect access to affordable care for vulnerable patients and safety‑net providers.
Chairlady Helton Haynes told the committee the amendment made three primary changes: it vests enforcement with the Attorney General’s office rather than splitting oversight with the Department of Commerce and Insurance; it allows pharmaceutical companies to keep contract‑pharmacy restrictions that existed as of June 1 but bars new restrictions after that date; and it adds language meant to ensure savings from the 340B drug pricing program are used in a manner consistent with federal and state laws regarding immigration, citizenship status, abortion, and transgender care for minors. The sponsor said the grandfathering clause removes the fiscal note.
With the amendment (drafting code 6851) adopted on the record, the clerk opened the vote and reported 11 ayes, 0 nos. The chair announced House Bill 12-42 will move to full finance.
The bill as amended addresses access to discounted drugs at contract pharmacies and assigns enforcement responsibility to the Attorney General. Committee minutes show the amendment removed the fiscal note, according to the sponsor’s description on the record.
